Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and Tauopathies
Irene López González, Paula Garcia‐Esparcia, Franc Llorens, et al.
International Journal of Molecular Sciences (2016) Vol. 17, Iss. 2, pp. 206-206
Open Access | Times Cited: 94

Showing 1-25 of 94 citing articles:

Neuroinflammation as a Common Feature of Neurodegenerative Disorders
Leonardo Guzmán‐Martínez, Ricardo B. Maccioni, Víctor Andrade, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 588
Glial contributions to neurodegeneration in tauopathies
Cheryl E. G. Leyns, David M. Holtzman
Molecular Neurodegeneration (2017) Vol. 12, Iss. 1
Open Access | Times Cited: 339
Microglia in Parkinson’s Disease
Margaret S. Ho
Advances in experimental medicine and biology (2019), pp. 335-353
Closed Access | Times Cited: 190
YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias
Franc Llorens, Katrin Thüne, Waqas Tahir, et al.
Molecular Neurodegeneration (2017) Vol. 12, Iss. 1
Open Access | Times Cited: 185
The Role of Sex and Sex Hormones in Neurodegenerative Diseases
Elisabetta Vegeto, Alessandro Villa, Sara Della Torre, et al.
Endocrine Reviews (2019) Vol. 41, Iss. 2, pp. 273-319
Open Access | Times Cited: 175
Alzheimer’s Disease: An Update and Insights Into Pathophysiology
Murtala Bello Abubakar, Kamaldeen Olalekan Sanusi, Azizah Ugusman, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 160
Exosomes derived from miR-188-3p-modified adipose-derived mesenchymal stem cells protect Parkinson’s disease
Qiang Li, Zihao Wang, Hao Xing, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 23, pp. 1334-1344
Open Access | Times Cited: 112
Microglial Phagocytosis and Its Regulation: A Therapeutic Target in Parkinson’s Disease?
Elżbieta Janda, Laura Boi, Anna R. Carta
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 151
Chronic intermittent hypoxia induces oxidative stress and inflammation in brain regions associated with early-stage neurodegeneration
Brina Snyder, Brent Shell, J. Thomas Cunningham, et al.
Physiological Reports (2017) Vol. 5, Iss. 9, pp. e13258-e13258
Open Access | Times Cited: 150
Pharmacological targeting of GSK-3 and NRF2 provides neuroprotection in a preclinical model of tauopathy
Antonio Cuadrado, Sebastian Kügler, Isabel Lastres‐Becker
Redox Biology (2017) Vol. 14, pp. 522-534
Open Access | Times Cited: 148
Prenatal Immune Challenge in Mice Leads to Partly Sex-Dependent Behavioral, Microglial, and Molecular Abnormalities Associated with Schizophrenia
Chin Wai Hui, Abygaël St-Pierre, Hassan El Hajj, et al.
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 139
A Unifying Hypothesis for Alzheimer’s Disease: From Plaques to Neurodegeneration
Frances A. Edwards
Trends in Neurosciences (2019) Vol. 42, Iss. 5, pp. 310-322
Open Access | Times Cited: 121
Pharmacological Targeting of Microglial Activation: New Therapeutic Approach
Caiyun Liu, Xu Wang, Chang Liu, et al.
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 114
Diversity of astroglial responses across human neurodegenerative disorders and brain aging
Isidró Ferrer
Brain Pathology (2017) Vol. 27, Iss. 5, pp. 645-674
Open Access | Times Cited: 100
Sulforaphane attenuates microglia-mediated neuronal necroptosis through down-regulation of MAPK/NF-κB signaling pathways in LPS-activated BV-2 microglia
Sisi Qin, Canhong Yang, Weihua Huang, et al.
Pharmacological Research (2018) Vol. 133, pp. 218-235
Closed Access | Times Cited: 94
Revisiting the neuroinflammation hypothesis in Alzheimer’s disease: a focus on the druggability of current targets
Maylin Wong-Guerra, Camila Calfío, Ricardo B. Maccioni, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 40
Biological characteristics and transcriptomic profile of adipose-derived mesenchymal stem cells isolated from prion-infected murine model
Mohammed Zayed, Yong‐Chan Kim, Byung‐Hoon Jeong
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Protective effects of flavonoids against Alzheimer’s disease-related neural dysfunctions
Mahsa Bakhtiari, Yunes Panahi, J Ameli, et al.
Biomedicine & Pharmacotherapy (2017) Vol. 93, pp. 218-229
Closed Access | Times Cited: 85
Shared mechanisms among neurodegenerative diseases: from genetic factors to gene networks
Douglas Arneson, Yong Zhang, Xia Yang, et al.
Journal of Genetics (2018) Vol. 97, Iss. 3, pp. 795-806
Open Access | Times Cited: 63
The neuroinflammatory biomarker YKL-40 for neurodegenerative diseases: advances in development
Filippo Baldacci, Simone Lista, Giovanni Palermo, et al.
Expert Review of Proteomics (2019) Vol. 16, Iss. 7, pp. 593-600
Closed Access | Times Cited: 55
The oral microbiome and inflammation in mild cognitive impairment
Irene Yang, Robert A. Arthur, Liping Zhao, et al.
Experimental Gerontology (2021) Vol. 147, pp. 111273-111273
Closed Access | Times Cited: 46
Physiology and Pathology of Aging
Calvin H. Hirsch, Ana Hategan
Springer eBooks (2024), pp. 3-29
Closed Access | Times Cited: 6
Inflammation in Lafora Disease: Evolution with Disease Progression in Laforin and Malin Knock-out Mouse Models
Irene López‐González, Rosa Viana, Pascual Sanz, et al.
Molecular Neurobiology (2016) Vol. 54, Iss. 5, pp. 3119-3130
Open Access | Times Cited: 56
Boosting phagocytosis and anti‐inflammatory phenotype in microglia mediates neuroprotection by PPARγ agonist MDG548 in Parkinson's disease models
Daniela Lecca, Elżbieta Janda, Giovanna Mulas, et al.
British Journal of Pharmacology (2018) Vol. 175, Iss. 16, pp. 3298-3314
Open Access | Times Cited: 55
Understanding the role of SOCS signaling in neurodegenerative diseases: Current and emerging concepts
Antonia Cianciulli, Rosa Calvello, Chiara Porro, et al.
Cytokine & Growth Factor Reviews (2017) Vol. 37, pp. 67-79
Closed Access | Times Cited: 53
Page 1 - Next Page

Scroll to top